Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1430306
Sentiment: neutral
Topics: 8-K, operations-update, sec-filing
Related Tickers: TNXP
TL;DR
TNXP filed an 8-K on July 25th, expect updates on operations and other news.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 25, 2025, reporting on its results of operations and other events. The filing does not contain specific financial figures or details about the 'other events' at this time.
Why It Matters
This filing indicates that Tonix Pharmaceuticals is providing updates on its operational results and other significant corporate events to the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting form without immediate financial implications or significant new disclosures.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- July 25, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of Incorporation
- 001-36019 (identifier) — SEC File Number
- 261434750 (identifier) — IRS Employer Identification No.
- 26 Main Street, Suite 101, Chatham, New Jersey 07928 (address) — Principal executive offices
- (862) 799-8599 (phone_number) — Registrant's telephone number
FAQ
What specific events are being reported under 'Other Events'?
The provided text for the 8-K filing does not specify the details of the 'Other Events'.
What are the 'Results of Operations and Financial Condition' being reported?
The filing indicates a report on Results of Operations and Financial Condition, but the specific financial details are not included in the provided text.
When was this Form 8-K filed?
This Form 8-K was filed on July 25, 2025.
What is the company's state of incorporation and SEC file number?
The company is incorporated in Nevada and its SEC file number is 001-36019.
What is the principal executive office address and phone number?
The principal executive offices are located at 26 Main Street, Suite 101, Chatham, New Jersey 07928, and the telephone number is (862) 799-8599.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).